Monitoring Fetal Heart Rate and Rhythm in High-Risk Pregnancies for Arrhythmias: Insights from the Fetal Heart Society
By
Stacy A. S. Killen
Sheetal Patel
Nitin Madan
Maria Kiaffas
Shardha Srinivasan
Jacqueline Shuplock
Joyce Johnson
Whitnee Hogan
Miwa Geiger
Lisa Hornberger
Anita Moon-Grady
Bettina Cuneo
May 27, 2026
Clinical Scorecard: Monitoring Fetal Heart Rate and Rhythm in High-Risk Pregnancies for Arrhythmias: Insights from the Fetal Heart Society
At a Glance
Category Detail
Condition Key Mechanisms Includes tachycardias (e.g., SVT, VT), bradycardias, and irregular rhythms requiring close surveillance. Target Population Care Setting
Key Highlights
90-95% of fetuses with high-risk arrhythmias can be live-born with early detection and management. Ambulatory fetal heart rate monitoring (FHRM) is a feasible method for detecting arrhythmias. FHRM can empower pregnant individuals and does not increase stress levels. FHRM devices are not currently FDA approved for use by individuals without medical training. Guideline-Based Recommendations
Diagnosis
Management
FHRM frequency is determined by the fetal care provider in shared decision-making with the pregnant individual. Monitoring & Follow-up
Risks
Patient & Prescribing Data
FHRM devices can be loaned or purchased, with education provided on their use. Note potential costs and insurance coverage issues.
Clinical Best Practices
Educate pregnant individuals on FHRM usage and monitoring frequency. Encourage tracking of FHR trends and communication with providers regarding concerns, emphasizing timely communication. Related Resources & Content
